Treating hypertriglyceridemia

CMAJ. 2007 Sep 11;177(6):603-4; author reply 604-5. doi: 10.1503/cmaj.1070056.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Adult
  • Clofibric Acid / therapeutic use
  • Coronary Artery Disease / blood
  • Diet
  • Exercise
  • Heparin / therapeutic use*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hypertriglyceridemia / classification
  • Hypertriglyceridemia / diagnosis
  • Hypertriglyceridemia / etiology*
  • Hypertriglyceridemia / therapy*
  • Hypolipidemic Agents / therapeutic use
  • Insulin / therapeutic use*
  • Male
  • Niacin / therapeutic use
  • Pancreatitis / blood
  • Plasmapheresis
  • Practice Guidelines as Topic
  • Risk Factors
  • Triglycerides / blood
  • Weight Loss

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypolipidemic Agents
  • Insulin
  • Triglycerides
  • Niacin
  • Clofibric Acid
  • Heparin